Kaya, E. Et Al. 2024. Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunction. Expert Opinion on Investigational Drugs , vol.33, no.12 , 1167-1176.

Kaya, E., YILMAZ, Y., & Alkhouri, N., (2024). Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunction. Expert Opinion on Investigational Drugs , vol.33, no.12, 1167-1176.

Kaya, Eda, YUSUF YILMAZ, And Naim Alkhouri. "Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunction," Expert Opinion on Investigational Drugs , vol.33, no.12, 1167-1176, 2024

Kaya, Eda Et Al. "Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunction." Expert Opinion on Investigational Drugs , vol.33, no.12, pp.1167-1176, 2024

Kaya, E. YILMAZ, Y. And Alkhouri, N. (2024) . "Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunction." Expert Opinion on Investigational Drugs , vol.33, no.12, pp.1167-1176.

@article{article, author={Eda Kaya Et Al. }, title={Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunction}, journal={Expert Opinion on Investigational Drugs}, year=2024, pages={1167-1176} }